FRNM on Nasdaq

Freenome, Inc.

American medical laboratories services company based in South San Francisco.

Price unavailable

Last updated Oct 18, 2026.

Overview

Compare with another stock.

TickerFRNM on Nasdaq
IndustryServices-Medical Laboratories
HeadquartersSouth San Francisco, United States
Incorporated inDE²
Business addressGenesis Marina, 3300 Marina Blvd, Brisbane, Ca 94005²
Filer categoryNon-accelerated filer, Smaller reporting company, Emerging growth company²

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Every line of the income statement as filed: the last 1 fiscal year, latest first.³

Period ending	2025-12-31
General and administrative expenses	$3.0M
Loss from operations	-$3.0M
Interest earned on investments held in Trust Account	$3.8M
Unrealized (loss) gain on investments held in Trust Account	-$3.3K
Total other income, net	$3.8M
Net income	$837.5K

Total assets³$92.8M in 2025+3% since 2024

Total liabilities³$5.7M in 2025+56% since 2024

Shareholders’ equity³-$4.8M in 2025+127% since 2024

Cash³$865.0K in 2025−23% since 2024

Every line of the balance sheet as filed: the last 3 fiscal years (annual) or 3 quarters (quarterly), latest first.³

Period ending	2025-12-31	2024-12-31	2024-03-31
Cash	$865.0K	$1.1M
Prepaid expenses	$42.5K	$115.0K
Total Current Assets	$907.6K	$1.2M
Cash and investments held in Trust Account	$91.9M	$88.7M
Total Assets	$92.8M	$89.9M
Accrued expenses	$2.3M	$210.8K
Total Current Liabilities	$2.3M	$210.8K
Deferred underwriting fee	$3.5M	$3.5M
Total Liabilities	$5.7M	$3.7M
Class A ordinary shares subject to possible redemption, 8,625,000 shares at redemption value of approximately $10.65 and $10.24 per share as of December 31, 2025 and 2024, respectively	$91.9M	$88.4M
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding as of December 31, 2025 and 2024	$0	$0
Accumulated deficit	-$4.8M	-$2.1M
Total Shareholders Deficit	-$4.8M	-$2.1M	$0
Total Liabilities and Shareholders Deficit	$92.8M	$89.9M
Preference shares, par value (in Dollars per share)	$0.00	$0.00
Preference shares, shares authorized (in Shares)	1.0M shares	1.0M shares
Preference shares, shares issued (in Shares)	0 shares	0 shares
Preference shares, shares outstanding (in Shares)	0 shares	0 shares

Period ending	2025-12-31	2024-12-31	2024-03-31
Cash	$865.0K	$1.1M
Prepaid expenses	$42.5K	$115.0K
Total Current Assets	$907.6K	$1.2M
Cash and investments held in Trust Account	$91.9M	$88.7M
Total Assets	$92.8M	$89.9M
Accrued expenses	$2.3M	$210.8K
Total Current Liabilities	$2.3M	$210.8K
Deferred underwriting fee	$3.5M	$3.5M
Total Liabilities	$5.7M	$3.7M
Class A ordinary shares subject to possible redemption, 8,625,000 shares at redemption value of approximately $10.65 and $10.24 per share as of December 31, 2025 and 2024, respectively	$91.9M	$88.4M
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding as of December 31, 2025 and 2024	$0	$0
Accumulated deficit	-$4.8M	-$2.1M
Total Shareholders Deficit	-$4.8M	-$2.1M	$0
Total Liabilities and Shareholders Deficit	$92.8M	$89.9M
Preference shares, par value (in Dollars per share)	$0.00	$0.00
Preference shares, shares authorized (in Shares)	1.0M shares	1.0M shares
Preference shares, shares issued (in Shares)	0 shares	0 shares
Preference shares, shares outstanding (in Shares)	0 shares	0 shares

Every line of the cash flow as filed: the last 1 fiscal year, latest first.³

Period ending	2025-12-31
Net income	$837.5K
Payment of operating costs through promissory note	$0
Interest earned on investments held in Trust Account	-$3.8M
Unrealized loss (gain) on investments held in Trust Account	$3.3K
Prepaid expenses and other current assets	$72.5K
Accrued expenses	$2.0M
Net cash used in operating activities	-$864.7K
Investment of cash in Trust Account	$0
Cash withdrawn from Trust Account for working capital purposes	$600.0K
Net cash provided by (used in) investing activities	$600.0K
Proceeds from sale of shares, net of underwriting discounts paid	$0
Proceeds from sale of Private Placement Shares	$0
Underwriter reimbursement	$0
Repayment of promissory note related party	$0
Payment of offering costs	$0
Net cash provided by financing activities	$0
Net Change in Cash	-$264.7K
Deferred offering costs paid directly by Sponsor in exchange for the issuance of Class B ordinary shares	$0
Deferred offering costs paid through promissory note - related party	$0

Compare Freenome, Inc. with another company

Leadership

Who has led Freenome, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

Adam Leo Stone2024

Chief financial officer

2025

Chief executive officerAdam Leo Stone Jun 11, 2024 to Jun 13, 2024⁸
Chief financial officerLinh H. Le Jul 27, 2026 to now⁹
Chief financial officerSam Shmuel Cohn Jun 11, 2024 to Jun 11, 2024¹⁰

Board members and other officers (15)

Chief Product OfficerRiley Charles Ennis Jul 27, 2026 to now¹¹
Chief Business OfficerMichael Seth Altman Jun 11, 2024 to Jun 13, 2024¹²
Board memberPeter Kolchinsky Jul 22, 2026 to now¹³
Board memberRajeev M. Shah Jul 22, 2026 to now¹³
Board memberAnn Catherine Costello Jul 27, 2026 to now¹⁴
Board memberCarole Nuechterlein Jul 27, 2026 to now¹⁵
Board memberDeepika Pakianathan Jul 27, 2026 to now¹⁶
Board memberOort Douglas M. Van Jul 27, 2026 to now¹⁷
Board memberRandal W. Scott Jul 27, 2026 to now¹⁸
Board memberAdam Leo Stone Jun 11, 2024 to Jun 13, 2024⁸
Board memberHarlan Waksal Jun 11, 2024 to Jun 11, 2024¹⁹
Board memberJoseph Edelman Jun 11, 2024 to Jun 11, 2024²⁰
Board memberKenneth Song Jun 11, 2024 to Jun 11, 2024²¹
Board memberMark C. McKenna Jun 11, 2024 to Jun 11, 2024²²
Board memberMichael Seth Altman Jun 11, 2024 to Jun 13, 2024¹²

Former names

Perceptive Capital Solutions CorpApr 16, 2024 to Jul 15, 2026²

Timeline

Jun 11, 2024New chief executive Adam Leo Stone becomes CEO⁸

Filings

132 filings to the SEC since October 2021: 2 annual reports, 7 quarterly reports, 11 major events, 31 insider forms, 30 large holders, 51 other. The latest 20:

Sep 23, 2026S-8 EDGAR
Sep 4, 20264 EDGAR
Sep 1, 2026SCHEDULE 13G EDGAR
Aug 27, 2026EFFECT EDGAR
Aug 27, 2026424B3 EDGAR
Aug 18, 2026S-1 EDGAR
Aug 14, 2026SCHEDULE 13G/A EDGAR
Aug 14, 2026SCHEDULE 13G EDGAR
Aug 13, 20268-K/A EDGAR
Aug 12, 2026SCHEDULE 13G/A EDGAR
Aug 12, 2026SCHEDULE 13G/A EDGAR
Aug 5, 2026SCHEDULE 13G/A EDGAR
Jul 29, 2026EFFECT EDGAR
Jul 29, 20264 EDGAR
Jul 28, 2026POS AM EDGAR
Jul 27, 2026SCHEDULE 13G EDGAR
Jul 27, 20263 EDGAR
Jul 27, 20263 EDGAR
Jul 27, 20263 EDGAR
Jul 27, 20263 EDGAR

The 132 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last three years, summarized. The full record is on SEC EDGAR.

Insider trades and holders

Large holders

Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 30 such filings since October 2021, the latest 10:

From Forms 4 and Schedules 13D and 13G filed with the SEC.

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARFreenome, Inc. filings on SEC EDGAR
2
SEC EDGARFreenome, Inc. filings on SEC EDGAR
3
SEC EDGARFreenome, Inc. 10-K for fiscal 2025
4
SEC EDGARFreenome, Inc. 10-Q for fiscal 2025
5
SEC EDGARFreenome, Inc. 10-Q for fiscal 2025
6
SEC EDGARFreenome, Inc. 10-Q for fiscal 2026
7
SEC EDGARFreenome, Inc. 10-Q for fiscal 2025
8
SEC EDGARAdam Leo Stone, Chief executive officer
9
SEC EDGARLinh H. Le, Chief financial officer
10
SEC EDGARSam Shmuel Cohn, Chief financial officer
11
SEC EDGARRiley Charles Ennis, Chief Product Officer
12
SEC EDGARMichael Seth Altman, Chief Business Officer
13
SEC EDGARPeter Kolchinsky, Board member
14
SEC EDGARAnn Catherine Costello, Board member
15
SEC EDGARCarole Nuechterlein, Board member
16
SEC EDGARDeepika Pakianathan, Board member
17
SEC EDGAROort Douglas M. Van, Board member
18
SEC EDGARRandal W. Scott, Board member
19
SEC EDGARHarlan Waksal, Board member
20
SEC EDGARJoseph Edelman, Board member
21
SEC EDGARKenneth Song, Board member
22
SEC EDGARMark C. McKenna, Board member